- This meeting has passed.
New Directions in the Management of Recurrent Ovarian Cancer
April 16, 2019 @ 5:00 pm - 7:00 pm
In this interactive case-based activity, Mihaela Cristea, MD, City of Hope, will discuss emerging data on PARP inhibitors in the management of recurrent ovarian cancer and case studies that provide a framework for personalized care plans.
“To me, ANCO is the regional oncology expert with the deepest local knowledge and resources. Like most oncologists I rely on ASCO as my national educational organization, but ANCO is a key local connection and an ideal bridge to the offerings of ASCO. If you belong to ASCO you should also be a member of ANCO. Together they provide comprehensive resources for Northern California oncologists.”
Tyler Paul Johnson, MD
Stanford Cancer Center